Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 468-880-2 | CAS number: 102985-93-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://echa.europa.eu/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Endpoint summary
Administrative data
Description of key information
The substance was tested for skin sensitisation in a guinea pig maximisation test. Based on the results obtained from testing it was considered not sensitising to skin.
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2004-11-10 to 2004-12-04
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Version / remarks:
- 17 July 1992
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.2600 (Skin Sensitisation)
- Version / remarks:
- August 1996
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.6 (Skin Sensitisation)
- Version / remarks:
- Directive 92/69/EEC
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- guinea pig maximisation test
- Justification for non-LLNA method:
- The guinea pig maximisation test has been carried out as an animal test to predict human sensitization for over a decade and is recommended by international test guidelines such as OECD.
- Species:
- guinea pig
- Strain:
- Dunkin-Hartley
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: LAB-ALL Bt. Budapest, 1174 Hunyadi u. 7
- Weight at study initiation: The weight variation in animals involved in the study was not exceed ± 20 % of the mean weight.
- Housing: Animals were housed in macrolon cages, size III., with 3 or 2 animals/cage (42 x 42 x 19 cm).
- Acclimation period: 7 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20 ± 3 °C
- Humidity (%): 30 - 70 %
- Air changes (per hr): 8 - 12
- Photoperiod (hrs dark / hrs light): 12 hours daily from 6 a.m. to 6 p.m. (artificial light) - Route:
- intradermal and epicutaneous
- Vehicle:
- other: oleum helianthi
- Concentration / amount:
- For the intra-dermal application 0.1 mL formulated test item was injected at concentrations of 0.1, 1 and 5% (w/v). The test item was formulated in oleum helianthi. Two different concentrations were applied per animal to the hairless skin on the right and left flanks, and two animals were employed per concentration tested.
For the dermal application 0.5 mL of formulated test item was applied onto the skin of the animals at concentrations of 25, 50, 75% (w/v) in oleum helianthi, and in undiluted state. A closed patch exposure was employed by means of an occlusive bandage. Two animals/ two different concentrations were used. - Route:
- other: epicutaneous
- Vehicle:
- other: oleum helianthi
- Concentration / amount:
- For the intra-dermal application 0.1 mL formulated test item was injected at concentrations of 0.1, 1 and 5% (w/v). The test item was formulated in oleum helianthi. Two different concentrations were applied per animal to the hairless skin on the right and left flanks, and two animals were employed per concentration tested.
For the dermal application 0.5 mL of formulated test item was applied onto the skin of the animals at concentrations of 25, 50, 75% (w/v) in oleum helianthi, and in undiluted state. A closed patch exposure was employed by means of an occlusive bandage. Two animals/ two different concentrations were used. - No. of animals per dose:
- Test group: 10 animals
Control group: 5 animals - Details on study design:
- RANGE FINDING TESTS:
A series of test item concentrations was tested to identify any primary irritation caused by intra-dermal injection and dermal application. Three dose levels were tested in the preliminary dose range finding study to identify the primary irritation by intra-dermal injection and four dose levels by dermal application.
The test item was applied at concentrations of 0.1,1 and 5 % (w/v) for intradermal injection and 25, 50, 75 % (w/v) and in undiluted state for dermal application.
For the intra-dermal application 0.1 mL formulated test item was injected at concentrations of 0.1, 1 and 5 % (w/v). The test item was formulated in oleum helianthi. Two different concentrations were applied per animal to the hairless skin on the right and left flanks, and two animals were employed per concentration tested. For the dermal application 0.5 mL of formulated test item was applied onto the skin of the animals at concentrations of 25, 50, 75 % (w/v) in oleum helianthi, and in undiluted state. A closed patch exposure was employed by means of an occlusive bandage. Two animals/ two different concentrations were used.
MAIN STUDY
A. INDUCTION EXPOSURE
Main Study I: Intra-dermal Induction Exposure
Before starting the exposure an area of approximately 5x5 cm on the scapular region of animals was clipped free of hair and shaven close with care.
Intra-dermal treatment Test groups:
A row of three injections, six in all, was made on each side of test animals, as follows:
2 injections with 0.1 mL of Freund's complete adjuvant (FCA) mixed with physiological saline solution (1:1),
2 injections with 0.1 mL of the test item (5 %) homogenized in oleum helianthi,
2 injections with 0.1 mL of test item mixed with physiological saline solution and homogenized in Freund's complete adjuvant (5 %).
Control group:
The control animals were treated similarly as the test group however, the vehicle, without the test item was used for injections, as follows:
2 injections with 0.1 mL mix of Freund's complete adjuvant and physiological saline solution (1:1)(v/v),
2 injections with 0.1 mL of oleum helianthi,
2 injections with 0.1 mL of 50 v/v % oleum helianthi in a 1:1 mixture (v/v) of Freund's complete adjuvant and physiological saline solution.
Main study II: Dermal Induction Exposure
Six days after the intra dermal injections, in all animals the test area was painted with 0.5 mL of 10 % sodium lauryl sulphate in vaseline 24 h prior to topical induction application, in order to create a local irritation. Approximately 24 hours after painting, the test animals were exposed to test item and the control animals were treated with oleum helianthi as vehicle.
Closed patch was applied in the following manner: in case of the test animals 0.50ml of test item (in undiluted state) was spread on the surface prepared previously and covered with a standard (5x5 cm) size of porous gauze patch. The sample was secured by a piece of PVC tape and occluded with adhesive bandage. Control animals were treated dermally with 0.50 mL of oleum helianthi as vehicle and the dressing was prepared and applied as for the test animals.
The patches were left in place for 48 hours. At the end of exposure the bandage was removed and the excess material was wiped off.
Following the dermal induction treatment the animals were left untreated for 14 days prior to challenge.
B. CHALLENGE EXPOSURE
Main study III: Challenge Exposure
Two weeks after the dermal treatment the animals were exposed to the challenge dose, dermally. 24 hours before the challenge treatment the left and the right flank areas (5x5 cm) of each animal were prepared for application. The challenge was performed as a dermal exposure (Closed Patch Test). Left shaved flank areas of the animals (both the test and the control) were treated with 0.50 mL of the test item (in undiluted state). The right shaved flank areas were treated with 0.50 mL of oleum helianthi, in all cases. Time of exposure was 24 hours. - Positive control substance(s):
- no
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 100 %
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Clinical observations:
- none
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 100 %
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Clinical observations:
- none
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 100 %
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- none
- Key result
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 100 %
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- none
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- positive control
- Dose level:
- 100 %
- No. with + reactions:
- 0
- Total no. in group:
- 0
- Clinical observations:
- none
- Remarks on result:
- not measured/tested
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- positive control
- Dose level:
- 100 %
- No. with + reactions:
- 0
- Total no. in group:
- 0
- Clinical observations:
- none
- Remarks on result:
- not measured/tested
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- Challenge with the test item 2,2-Dimethyl-3-lauroyloxy-propanal evoked no positive responses in the test animals previously sensitised. At the same time, none of the animals proved to be positive in the control group. The net response value represented a sensitisation rate of 0 % as no indication for adverse skin reactions were noted (mean of scores was 0.00). Based on the results of the present study, the test item 2,2-Dimethyl-3-lauroyloxy-propanal was classified as non- sensitiser.
- Executive summary:
A skin sensitisation study was performed according to Magnusson-Kligman method using Freund's complete adjuvant technique to evaluate the sensitisation potential of test item 2,2-Dimethyl-3-lauroyloxy-propanal. 10 test animals were subjected to sensitisation procedures in a two-stage operation, i.e. an intra-dermal treatment and a topical application. The test item was used at the concentration of 5 % for intra-dermal injections and in undiluted state for dermal sensitisation treatment. The test area was painted with 0.5 mL of 10% sodium lauryl sulphate in vaseline 24 h prior to the topical induction application, in order to create a local irritation. Two weeks following the last induction exposure, a challenge dose (in undiluted state) was administered. Challenge was performed by dermal application of the test item. 5 control guinea pigs were simultaneously exposed to the vehicle during the sensitisation phase and they were treated with the test item (in undiluted state) in the case of challenge. No signs of contact sensitisation in guinea pigs were noted after the challenge phase. In the control and treated animals no reactions at all were observed and the mean of the scores was 0.00 according to the results of the 24th and 48th-hour readings.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not sensitising)
- Additional information:
A skin sensitisation study was performed according to Magnusson-Kligman method using Freund's complete adjuvant technique to evaluate the sensitisation potential of test item 2,2-Dimethyl-3-lauroyloxy-propanal. 10 test animals were subjected to sensitisation procedures in a two-stage operation, i.e. an intra-dermal treatment and a topical application. The test item was used at the concentration of 5% for intra-dermal injections and in undiluted state for dermal sensitisation treatment. The test area was painted with 0.5 mL of 10% sodium lauryl sulphate in vaseline 24 h prior to the topical induction application, in order to create a local irritation. Two weeks following the last induction exposure, a challenge dose (in undiluted state) was administered. Challenge was performed by dermal application of the test item. 5 control guinea pigs were simultaneously exposed to the vehicle during the sensitisation phase and they were treated with the test item (in undiluted state) in the case of challenge. No signs of contact sensitisation in guinea pigs were noted after the challenge phase. In the control and treated animals no reactions at all were observed and the mean of the scores was 0.00 according to the results of the 24th and 48th-hour readings.
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no study available
- Additional information:
According to Annex VIII Regulation (EC) No 1907/2008 no study has to be conducted.
Justification for classification or non-classification
Based on the results obtained from testing of skin sensitization, no classification and labelling is required according to Regulation (EC) No 1272/2008 (CLP), as amended for the fifteenth time in Regulation (EU) No 2020/1182.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)